Taher A.; Aoun E.; Sharara A.I.; Mourad F.; Gharzuddine W.; Koussa S.; Inati A.; Dhillon A.P.; Hoffbrand A.V.
(BASELALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, 2004)
Twelve thalassaemia major patients have been given deferiprone 75 mg-kg body weight daily as iron chelation therapy for 5 years. Their ages ranged from 18 to 34 years (mean 24.2) at the end of the study. Two patients were ...